Form 4 for BSX Boston Scientific
Accepted 2024-04-29 00:00:00 ET · period of report 2024-04-26 · accession 0001225208-24-005317 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-29 | 2024-04-26 | BSX | LUDWIG EDWARD J | Dir | M - OptEx | $17.37 | +9,818 | 51.2K | +24% | +$170.5K |
| D | 2024-04-29 | 2024-04-26 | BSX | LUDWIG EDWARD J | Dir | S - Sale+OE | $73.29 | -9,818 | 41.4K | -19% | -$719.6K |
| D | 2024-04-29 | 2024-04-26 | BSX | LUDWIG EDWARD J | Dir | M - OptEx | $17.37 | -9,818 | 0 | -100% | -$170.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-26 | M | A | 9,818 | $17.37 | 51,192 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-26 | S | D | 9,818 | $73.29 | 41,374 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-04-26 | M | D | 9,818 | $17.37 | 0 | D | $17.37 · — to 2025-05-05 | 9,818 Common Stock | (F1) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in full on May 3, 2016, the date of the Company's 2016 annual meeting of stockholders. |